Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures.

Latest News

Share this

Press Release

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

New third-generation cerebral embolic protection device offers improvements to further guard the brain from emboli during heart procedures including TAVR   CAESAREA, Israel, and TAMPA, Florida — August 1st, 2017 —  Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients...

Keystone Heart Applauds FDA Advisory Panel

Panel feedback echoes recently published NeuroARC research guidelines CAESAREA, Israel, and TAMPA, Florida — February 27, 2017— Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, applauds the members of the FDA’s Circulatory System Devices...

Delirium Significantly Associated with Brain Lesions in Patients Post-TAVR According to New Data Released at TCT 2016

According to New Data Released at TCT 2016 Delirium Significantly Associated with Brain Lesions in Patients Post-TAVR CAESAREA, Israel, and TAMPA, Florida --November 1, 2016 — Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, today...

American Journal of Cardiology Reports Data Showing New Brain Lesions in 94% of Patients Following TAVR

Data Supports Potential Need for TriGuard™ Cerebral Embolic Protection device being developed by Keystone Heart American Journal of Cardiology Reports Data Showing New Brain Lesions in 94% of Patients Following TAVR CAESAREA, Israel & TAMPA, Fla.--September 30, 2016 — Keystone Heart Ltd., an emerging medical device company focused...

TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in Brain Protection in Patients Undergoing TAVR Procedures

New data presented at PCR London Valves conference TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in Brain Protection in Patients Undergoing TAVR Procedures CAESAREA, Israel & TAMPA, Fla.--September 19, 2016 — Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for...

Keystone Heart Ltd. Announces First Patient Enrolled in New Study to Protect the Brain During TAVR

Supporting data to be presented at Transcatheter Valve Therapies (TVT) Conference Keystone Heart Ltd. Announces First Patient Enrolled in New Study to Protect the Brain During TAVR CAESAREA, Israel & TAMPA, Fla.--(BUSINESS WIRE)--Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients...